Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab
29/04/2026 06:58
April 29 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says in a statement: EUROPEAN COMMISSION GRANTED APPROVAL FOR TUYORY, ITS BIOSIMILAR TO TOCILIZUMAB, IN MULTIPLE INDICATIONS TUYORY IS BIOSIMILAR TO ROACTEMRA TOCILIZUMAB APPROVAL APPLICABLE FOR THE EU, ICELAND, LICHTENSTEIN AND NORWAY TUYORY HAS BEEN DEVELOPED JOINTLY BY RICHTER AND MOCHIDA PHARMACEUTICAL Source text: [https://bet.hu/newkibdata/129448445/Tuyory_EC_approval_Apr2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab